Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

DISHMAN PHARMA vs BIOCON - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    DISHMAN PHARMA BIOCON DISHMAN PHARMA/
BIOCON
 
P/E (TTM) x 30.0 36.7 81.8% View Chart
P/BV x 3.3 4.1 81.3% View Chart
Dividend Yield % 0.7 0.2 375.0%  

Financials

 DISHMAN PHARMA   BIOCON
EQUITY SHARE DATA
    DISHMAN PHARMA
Mar-16
BIOCON
Mar-22
DISHMAN PHARMA/
BIOCON
5-Yr Chart
Click to enlarge
High Rs374424 88.3%   
Low Rs129315 40.9%   
Sales per share (Unadj.) Rs197.068.2 289.0%  
Earnings per share (Unadj.) Rs21.28.2 260.0%  
Cash flow per share (Unadj.) Rs34.714.9 232.4%  
Dividends per share (Unadj.) Rs2.000.50 400.0%  
Avg Dividend yield %0.80.1 587.3%  
Book value per share (Unadj.) Rs179.968.5 262.4%  
Shares outstanding (eoy) m80.701,200.60 6.7%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x1.35.4 23.6%   
Avg P/E ratio x11.945.3 26.2%  
P/CF ratio (eoy) x7.324.7 29.3%  
Price / Book Value ratio x1.45.4 25.9%  
Dividend payout %9.46.1 153.8%   
Avg Mkt Cap Rs m20,307443,622 4.6%   
No. of employees `000NANA-   
Total wages/salary Rs m5,35518,801 28.5%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m15,89881,840 19.4%  
Other income Rs m2656,891 3.9%   
Total revenues Rs m16,16388,731 18.2%   
Gross profit Rs m4,10313,827 29.7%  
Depreciation Rs m1,0918,142 13.4%   
Interest Rs m944676 139.7%   
Profit before tax Rs m2,33411,900 19.6%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m6242,115 29.5%   
Profit after tax Rs m1,7109,785 17.5%  
Gross profit margin %25.816.9 152.8%  
Effective tax rate %26.717.8 150.4%   
Net profit margin %10.812.0 90.0%  
BALANCE SHEET DATA
Current assets Rs m11,01883,823 13.1%   
Current liabilities Rs m9,51738,280 24.9%   
Net working cap to sales %9.455.6 17.0%  
Current ratio x1.22.2 52.9%  
Inventory Days Days57101 56.6%  
Debtors Days Days392 3.8%  
Net fixed assets Rs m18,787117,184 16.0%   
Share capital Rs m1616,003 2.7%   
"Free" reserves Rs m14,35476,281 18.8%   
Net worth Rs m14,51682,284 17.6%   
Long term debt Rs m4,18939,985 10.5%   
Total assets Rs m29,805201,007 14.8%  
Interest coverage x3.518.6 18.7%   
Debt to equity ratio x0.30.5 59.4%  
Sales to assets ratio x0.50.4 131.0%   
Return on assets %8.95.2 171.1%  
Return on equity %11.811.9 99.1%  
Return on capital %17.510.3 170.4%  
Exports to sales %24.90-   
Imports to sales %3.77.8 48.1%   
Exports (fob) Rs m3,956NA-   
Imports (cif) Rs m5946,360 9.3%   
Fx inflow Rs m4,9528,885 55.7%   
Fx outflow Rs m6976,360 11.0%   
Net fx Rs m4,2552,525 168.5%   
CASH FLOW
From Operations Rs m2,78611,766 23.7%  
From Investments Rs m-1,529-16,991 9.0%  
From Financial Activity Rs m-9412,421 -38.9%  
Net Cashflow Rs m317-2,433 -13.0%  

Share Holding

Indian Promoters % 61.4 39.7 154.8%  
Foreign collaborators % 0.0 21.0 -  
Indian inst/Mut Fund % 23.0 23.6 97.5%  
FIIs % 12.0 15.8 75.8%  
ADR/GDR % 0.0 0.0 -  
Free float % 38.6 39.4 98.1%  
Shareholders   52,291 369,816 14.1%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare DISHMAN PHARMA With:   SUN PHARMA    DR. REDDYS LAB    CIPLA    LUPIN    AUROBINDO PHARMA    


More on Dishman Pharma vs Biocon

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

Dishman Pharma vs Biocon Share Price Performance

Period Dishman Pharma Biocon S&P BSE HEALTHCARE
1-Day 2.87% 2.99% 0.33%
1-Month -2.45% 3.75% 0.28%
1-Year 96.38% -22.19% -6.55%
3-Year CAGR 50.28% 2.95% 20.31%
5-Year CAGR 41.17% -7.42% 10.96%

* Compound Annual Growth Rate

Here are more details on the Dishman Pharma share price and the Biocon share price.

Moving on to shareholding structures...

The promoters of Dishman Pharma hold a 61.4% stake in the company. In case of Biocon the stake stands at 60.6%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of Dishman Pharma and the shareholding pattern of Biocon.

Finally, a word on dividends...

In the most recent financial year, Dishman Pharma paid a dividend of Rs 2.0 per share. This amounted to a Dividend Payout ratio of 9.4%.

Biocon paid Rs 0.5, and its dividend payout ratio stood at 6.1%.

You may visit here to review the dividend history of Dishman Pharma, and the dividend history of Biocon.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Ends 21 Points Higher | BHEL, RVNL Surge 10% to Hit 52-Week High | Why PNB Share Price is Rising(Closing)

Indian share markets traded in a rangebound manner throughout today's session to end flat.